RHONE MA HOLDINGS BERHAD

KLSE: 5278 (RHONEMA)

最近更新时间: 10 Apr, 3:45PM

0.635

0.01 (1.60%)

前收盘价格 0.625
收盘价格 0.635
成交量 2,000
平均成交量 (3个月) 38,910
市值 140,478,512
市盈率 (P/E TTM) 15.88
价格/销量 (P/S) 0.890
股市价格/股市净资产 (P/B) 0.820
52周波幅
0.580 (-8%) — 0.800 (25%)
股息率 (DY TTM) 3.94%
营业毛利率 5.81%
营业利益率 (TTM) 10.34%
稀释每股收益 (EPS TTM) 0.040
季度收入增长率 (YOY) -5.00%
季度盈利增长率 (YOY) -5.80%
总债务/股东权益 (D/E MRQ) 13.42%
流动比率 (MRQ) 5.27
营业现金流 (OCF TTM) 18.84 M
杠杆自由现金流 (LFCF TTM) 13.85 M
资产报酬率 (ROA TTM) 5.59%
股东权益报酬率 (ROE TTM) 7.43%

市场趋势

短期 中期
行业 Drug Manufacturers - Specialty & Generic (MY) 混合的 混合的
Drug Manufacturers - Specialty & Generic (全球的) 混合的 混合的
股票 RHONEMA 混合的 混合的

AIStockmoo 评分

1.5
分析师共识 NA
内部交易活动 3.0
价格波动 3.5
技术平均移动指标 0.0
技术振荡指标 -0.5
平均 1.50

相关股票

股票 市值 DY P/E(TTM) P/B
RHONEMA 140 M 3.94% 15.88 0.820
KOTRA 586 M 6.46% 14.63 2.27
YSPSAH 298 M 5.24% 11.05 0.730
PLABS 59 M - 21.50 0.690
DPHARMA 1 B 2.54% 16.86 1.60

Rhone Ma Holdings Bhd is an investment holding company and are engaged in the provision of management services. It operates through its subsidiaries so it offers animal health services as well as the manufacturing and distribution of animal health products. The operating segments of the group are Animal health products and equipment , Food ingredients, and Others. Animal health products and equipment segment includes marketing, trading, distribution and manufacturing of animal health products and undertaking research and development activities related to animal health, food safety and agriculture in animal health products. The animal health products offered include vaccines, pharmaceuticals, and feed additives. It is also involved in the distribution and supply of food ingredients.

部门 Healthcare
行业 Drug Manufacturers - Specialty & Generic
投资方式 Small Value
内部持股比例 85.99%
机构持股比例 1.36%

该时间范围内无数据。

名称 平均购买 ($) 平均卖出 ($) 总净额 总净值 ($)
DR LIM BAN KEONG 0.650 - 100,000 65,000
累积净数量 100,000
累积净值 ($) 65,000
累积平均购买 ($) 0.650
累积平均卖出 ($) -
名称 持有人 日期 类型 数量 价格 价值 ($)
DR LIM BAN KEONG 董事 07 Apr 2025 获得 (+) 50,000 0.650 32,500
DR LIM BAN KEONG 大股东 07 Apr 2025 获得 (+) 50,000 0.650 32,500
日期 类型 细节
16 Apr 2025 公告 RHONEMA - Notice of Book Closure
07 Apr 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
07 Apr 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
07 Apr 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
03 Apr 2025 TheEdge Cover Story: Fatter dividends declared in FY2024 ahead of 2% dividend tax
13 Mar 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
13 Mar 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
13 Mar 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - TEO KWEE HOCK
13 Mar 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
12 Mar 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
12 Mar 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
12 Mar 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
11 Mar 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
11 Mar 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
11 Mar 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
07 Mar 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
07 Mar 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
07 Mar 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
05 Mar 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
05 Mar 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
05 Mar 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
04 Mar 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - MR FOONG KAM WENG
04 Mar 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR FOONG KAM WENG
04 Mar 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
03 Mar 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
03 Mar 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
03 Mar 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
21 Feb 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
21 Feb 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
21 Feb 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
20 Feb 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
20 Feb 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
20 Feb 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
19 Feb 2025 公告 Quarterly rpt on consolidated results for the financial period ended 31/12/2024
19 Feb 2025 公告 Rhone Ma Holdings Berhad ("RMH" or "Company") - Extension of Time for the Utilisation of Proceeds raised from the Private Placement.
19 Feb 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
19 Feb 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
19 Feb 2025 公告 Press Release: Rhone Ma Holdings Berhad Delivers Strong FYE2024 Performance, Recording RM211.6 Million in Revenue
19 Feb 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
31 Jan 2025 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
31 Jan 2025 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
31 Jan 2025 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
显示更多
股息率 (DY TTM) 3.94%
5年平均股息收益率 2.72%
股息支付比率 61.27%
预计下次股息支付 Jul 2025
除息日 公告日期 支付日期 详情
13 Dec 2024 18 Nov 2024 27 Dec 2024 0.01 现金
22 Oct 2024 08 Oct 2024 04 Nov 2024 0.005 现金
27 Jun 2024 16 Apr 2024 15 Jul 2024 0.01 现金
05 Jan 2024 15 Dec 2023 02 Feb 2024 0.01 现金
28 Jun 2023 11 Apr 2023 17 Jul 2023 0.01 现金
30 Dec 2022 15 Dec 2022 16 Jan 2023 0.01 现金
01 Jul 2022 12 Apr 2022 15 Jul 2022 0.01 现金
12 Jan 2022 24 Dec 2021 25 Jan 2022 0.01 现金
01 Jul 2021 04 Jun 2021 15 Jul 2021 0.01 现金
02 Jul 2020 06 May 2020 15 Jul 2020 0.01 现金
02 Jul 2019 29 Apr 2019 15 Jul 2019 0.02 现金
29 Jan 2019 15 Jan 2019 13 Feb 2019 0.01 现金
显示更多

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2024 0.035 4 5.19
2023 0.020 2 2.90
2022 0.020 2 2.94
2021 0.010 1 1.35
2020 0.010 1 1.24
2019 0.030 2 4.51
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票